- Home
- AWRE vs QNTM Comparison
AWRE vs QNTM Comparison
Compare AWRE & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWRE
- QNTM
- Stock Information
- Founded
- AWRE 1986
- QNTM 1998
- Country
- AWRE United States
- QNTM Canada
- Employees
- AWRE N/A
- QNTM N/A
- Industry
- AWRE Computer Software: Prepackaged Software
- QNTM
- Sector
- AWRE Technology
- QNTM
- Exchange
- AWRE Nasdaq
- QNTM NYSE
- Market Cap
- AWRE 34.6M
- QNTM 35.6M
- IPO Year
- AWRE 1996
- QNTM N/A
- Fundamental
- Price
- AWRE $1.68
- QNTM $13.46
- Analyst Decision
- AWRE
- QNTM
- Analyst Count
- AWRE 0
- QNTM 0
- Target Price
- AWRE N/A
- QNTM N/A
- AVG Volume (30 Days)
- AWRE 29.9K
- QNTM 210.7K
- Earning Date
- AWRE 04-30-2025
- QNTM 05-14-2025
- Dividend Yield
- AWRE N/A
- QNTM N/A
- EPS Growth
- AWRE N/A
- QNTM N/A
- EPS
- AWRE N/A
- QNTM N/A
- Revenue
- AWRE $16,576,000.00
- QNTM N/A
- Revenue This Year
- AWRE N/A
- QNTM N/A
- Revenue Next Year
- AWRE N/A
- QNTM N/A
- P/E Ratio
- AWRE N/A
- QNTM N/A
- Revenue Growth
- AWRE N/A
- QNTM N/A
- 52 Week Low
- AWRE $1.35
- QNTM $2.70
- 52 Week High
- AWRE $2.97
- QNTM $23.81
- Technical
- Relative Strength Index (RSI)
- AWRE 55.69
- QNTM 73.02
- Support Level
- AWRE $1.60
- QNTM $10.75
- Resistance Level
- AWRE $1.72
- QNTM $13.44
- Average True Range (ATR)
- AWRE 0.07
- QNTM 1.39
- MACD
- AWRE -0.00
- QNTM 0.22
- Stochastic Oscillator
- AWRE 71.43
- QNTM 83.46
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.